V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016042 | 240007639 | null | null | Palliative (P) | null | 2018-03-02 | Carboplatin AUC 2 - 5 | 2 | N | 240030248 | CARBOPLATIN |
| 240016043 | 240014202 | 1.61 | null | Palliative (P) | 2014-07-05 | 2014-07-13 | Trial Unspecified | N | N | 240030324 | TRIAL |
| 240016044 | 240007653 | 1.78 | 59.7 | Neo-adjuvant (N) | 2017-07-01 | 2017-11-23 | Bevacizumab 15mg/kg | 2 | N | 240030340 | BEVACIZUMAB |
| 240016045 | 240012110 | 1.65 | null | Palliative (P) | 2019-05-07 | 2019-05-10 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 240030350 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016046 | 240007667 | 1.62 | null | null | 2014-04-16 | 2014-04-29 | CHOP - 21 days | 02 | N | 240030419 | CHOP |
| 240016047 | 240007672 | null | 77.7 | Palliative (P) | 2015-08-14 | 2015-11-07 | Azacitidine | N | N | 240030445 | AZACITIDINE |
| 240016048 | 240007683 | 0 | 84.3 | null | 2016-03-19 | 2016-03-25 | CHOP | 02 | N | 240030505 | CHOP |
| 240016049 | 240007696 | 1.75 | null | Palliative (P) | null | 2016-08-06 | PACLITAXEL | 02 | N | 240030611 | PACLITAXEL |
| 240016050 | 240014222 | null | 70.5 | Palliative (P) | 2019-10-05 | 2019-10-06 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240030734 | NOT MATCHED |
| 240016051 | 240007722 | 1.5 | null | null | 2015-08-18 | 2015-08-25 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030756 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016052 | 240007724 | 1.63 | 50.8 | Curative (C) | 2017-09-20 | 2017-10-03 | Bevacizumab | N | N | 240030765 | BEVACIZUMAB |
| 240016053 | 240007735 | 1.8 | 117 | Curative (C) | 2016-06-20 | 2016-06-20 | CHOP - 21 days | 2 | N | 240030813 | CHOP |
| 240016054 | 240015293 | 0 | null | null | 2019-08-19 | 2019-08-20 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030997 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016055 | 240012181 | 1.73 | 72.8 | Disease modification (D) | 2019-07-02 | 2019-07-28 | SMILE | N | N | 240031101 | TRIAL |
| 240016056 | 240007800 | null | 87.2 | Curative (C) | 2017-08-06 | 2017-09-01 | INTERLACE TRIAL | 02 | null | 240031218 | INTERLACE TRIAL |
| 240016057 | 240016105 | 0 | 80 | Disease modification (D) | 2018-08-22 | 2018-12-24 | Azacitidine | N | N | 240031228 | AZACITIDINE |
| 240016058 | 240007805 | 1.65 | 72.2 | Palliative (P) | 2018-07-02 | 2018-07-10 | CARBOPLATIN | 2 | N | 240031247 | CARBOPLATIN |
| 240016059 | 240007815 | 1.55 | 65 | Palliative (P) | 2019-06-25 | 2019-07-02 | Bevacizumab+Carbo+Pacliaxel | Y | null | 240031288 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016060 | 240007821 | 1.74 | 51 | Palliative (P) | 2017-07-28 | 2017-07-29 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031315 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016061 | 240007840 | null | 68.3 | Disease modification (D) | 2018-01-31 | 2018-02-05 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | null | 240031447 | NOT MATCHED |
| 240016062 | 240007866 | 1.64 | 63.6 | Curative (C) | 2013-07-01 | 2013-07-05 | Methotrexate intrathecal | 2 | N | 240031652 | METHOTREXATE INTRATHECAL |
| 240016063 | 240007870 | null | 62.1 | Adjuvant (A) | 2018-07-23 | 2018-08-31 | INTERLACE TRIAL | 02 | N | 240031664 | INTERLACE TRIAL |
| 240016064 | 240007898 | 1.61 | null | Palliative (P) | 2018-08-31 | 2018-08-31 | Trial Unspecified | N | N | 240031746 | TRIAL |
| 240016065 | 240007901 | null | 76.6 | Curative (C) | 2017-10-02 | 2017-10-02 | Hydroxycarbamide | 02 | N | 240031748 | DHAP |
| 240016066 | 240007922 | null | 69.7 | Curative (C) | 2017-05-01 | 2017-05-11 | CYCLOPHOSPHAMIDE | N | null | 240031919 | R IVAC |
| 240016067 | 240007954 | 1.58 | null | Not known (9) | 2018-05-20 | 2018-05-23 | Brentuximab | 02 | N | 240032061 | BRENTUXIMAB |
| 240016068 | 240007959 | 1.69 | 70.4 | null | 2014-03-26 | 2014-05-02 | Cyclophosphamide + Dex + Rituximab | N | N | 240032094 | GEMCITABINE |
| 240016069 | 240007982 | 1.75 | 80.9 | Adjuvant (A) | 2016-03-28 | 2016-03-28 | Hydroxycarbamide | 2 | N | 240032202 | LENALIDOMIDE |
| 240016070 | 240015843 | 1.58 | null | Curative (C) | null | 2016-06-03 | Hydroxycarbamide | null | null | 240032319 | BEAM |
| 240016071 | 240012289 | null | null | Curative (C) | 2018-05-24 | 2018-05-24 | Chlorambucil | 02 | N | 240032350 | CHLORAMBUCIL |
| 240016072 | 240008016 | 1.59 | 80.7 | Palliative (P) | 2018-10-05 | 2018-10-06 | Carboplatin + Etoposide IV 3 day | N | N | 240032395 | DHAP |
| 240016073 | 240015329 | 1.63 | 64 | Curative (C) | 2014-03-11 | 2014-04-06 | Carboplatin + Etoposide iv&po | N | null | 240032483 | BENDAMUSTINE |
| 240016074 | 240012304 | 1.71 | null | Curative (C) | 2017-03-02 | 2017-03-13 | GDP | N | N | 240032533 | BENDAMUSTINE |
| 240016075 | 240008048 | 1.61 | null | Curative (C) | 2016-08-12 | 2016-08-12 | CARBOPLATIN + ETOPOSIDE | 02 | N | 240032580 | DA |
| 240016076 | 240008050 | null | 55 | Curative (C) | 2016-09-20 | 2016-09-21 | ABVD | 02 | N | 240032590 | R IVAC |
| 240016077 | 240008054 | 1.8 | 55 | Palliative (P) | 2018-07-20 | 2018-12-02 | Bortezomib +/- Dexamethasone | N | N | 240032600 | HYDROXYCARBAMIDE |
| 240016078 | 240008062 | 1.76 | null | Palliative (P) | 2017-08-11 | 2017-08-12 | Cisplatin + Topotecan | N | N | 240032650 | METHOTREXATE |
| 240016079 | 240008107 | 1.7 | 86.1 | Not known (9) | 2016-05-21 | 2016-05-22 | R IVAC | 2 | N | 240033048 | BEAM |
| 240016080 | 240012348 | 1.61 | 55.6 | Palliative (P) | 2012-06-21 | 2015-03-06 | BEAM | N | N | 240033101 | CYCLOPHOSPHAMIDE |
| 240016081 | 240012354 | 1.62 | 64.2 | Palliative (P) | 2018-08-31 | 2018-09-04 | Cisplatin + Etoposide po&iv 3 day | N | N | 240033188 | BEAM |
| 240016082 | 240014348 | null | 77.1 | Palliative (P) | 2015-06-08 | 2015-06-08 | GDP | N | N | 240033321 | METHOTREXATE HIGH DOSE |
| 240016083 | 240008164 | 1.75 | 83.4 | Palliative (P) | 2017-03-04 | 2017-03-04 | ABVD | N | N | 240033393 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240016084 | 240008174 | 1.74 | 75.5 | Curative (C) | 2015-02-18 | 2015-03-15 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | Y | 240033485 | BENDAMUSTINE |
| 240016085 | 240008185 | 1.88 | 108 | Curative (C) | 2016-12-08 | 2016-12-08 | IBRUTINIB | null | null | 240033543 | CISPLATIN + TOPOTECAN |
| 240016086 | 240008203 | null | 62.3 | Palliative (P) | 2018-08-02 | 2018-08-02 | Cytarabine Low Dose | null | null | 240033648 | CISPLATIN + TOPOTECAN |
| 240016087 | 240008208 | 1.6 | 49 | Neo-adjuvant (N) | 2016-03-04 | 2016-03-04 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 240033661 | CHLORAMBUCIL + RITUXIMAB |
| 240016088 | 240008235 | 1.57 | 44 | Palliative (P) | 2018-06-13 | 2018-06-13 | CYCLOPHOSPHAMIDE | N | Y | 240033833 | TRASTUZUMAB |
| 240016089 | 240008254 | 1.65 | 80.1 | Disease modification (D) | 2016-11-13 | 2016-11-13 | R Chlorambucil | 02 | N | 240033963 | CHLORAMBUCIL + RITUXIMAB |
| 240016090 | 240008267 | 1.65 | 64.5 | Palliative (P) | 2019-10-23 | 2019-10-23 | CYCLOPHOSPHAMIDE | N | N | 240034019 | R IVAC |
| 240016091 | 240008271 | null | null | Palliative (P) | null | 2018-02-13 | R IVAC | N | null | 240034046 | R IVAC |